These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Modulating PCGF4/BMI1 Stability Is an Efficient Metastasis-Regulatory Strategy Used by Distinct Subtypes of Cancer-Associated Fibroblasts in Intrahepatic Cholangiocarcinoma. Hu J; Xu H; Ma X; Bai M; Zhou Y; Miao R; Wang F; Li X; Cheng B Am J Pathol; 2024 Jul; 194(7):1388-1404. PubMed ID: 38670529 [TBL] [Abstract][Full Text] [Related]
63. SHP-2-upregulated ZEB1 is important for PDGFRα-driven glioma epithelial-mesenchymal transition and invasion in mice and humans. Zhang L; Zhang W; Li Y; Alvarez A; Li Z; Wang Y; Song L; Lv D; Nakano I; Hu B; Cheng SY; Feng H Oncogene; 2016 Oct; 35(43):5641-5652. PubMed ID: 27041571 [TBL] [Abstract][Full Text] [Related]
64. RHBDD1 promotes colorectal cancer metastasis through the Wnt signaling pathway and its downstream target ZEB1. Zhang M; Miao F; Huang R; Liu W; Zhao Y; Jiao T; Lu Y; Wu F; Wang X; Wang H; Zhao H; Ju H; Miao S; Wang L; Song W J Exp Clin Cancer Res; 2018 Feb; 37(1):22. PubMed ID: 29426364 [TBL] [Abstract][Full Text] [Related]
67. Fibroblast growth factor receptor 4 promotes progression and correlates to poor prognosis in cholangiocarcinoma. Xu YF; Yang XQ; Lu XF; Guo S; Liu Y; Iqbal M; Ning SL; Yang H; Suo N; Chen YX Biochem Biophys Res Commun; 2014 Mar; 446(1):54-60. PubMed ID: 24565842 [TBL] [Abstract][Full Text] [Related]
68. Crenigacestat blocking notch pathway reduces liver fibrosis in the surrounding ecosystem of intrahepatic CCA viaTGF-β inhibition. Mancarella S; Gigante I; Serino G; Pizzuto E; Dituri F; Valentini MF; Wang J; Chen X; Armentano R; Calvisi DF; Giannelli G J Exp Clin Cancer Res; 2022 Nov; 41(1):331. PubMed ID: 36443822 [TBL] [Abstract][Full Text] [Related]
69. Tetraspanin 1 promotes epithelial-to-mesenchymal transition and metastasis of cholangiocarcinoma via PI3K/AKT signaling. Wang Y; Liang Y; Yang G; Lan Y; Han J; Wang J; Yin D; Song R; Zheng T; Zhang S; Pan S; Liu X; Zhu M; Liu Y; Cui Y; Meng F; Zhang B; Liang S; Guo H; Liu Y; Hassan MK; Liu L J Exp Clin Cancer Res; 2018 Dec; 37(1):300. PubMed ID: 30514341 [TBL] [Abstract][Full Text] [Related]
70. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition. Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486 [TBL] [Abstract][Full Text] [Related]
71. Matricellular proteins in intrahepatic cholangiocarcinoma. Sirica AE Adv Cancer Res; 2022; 156():249-281. PubMed ID: 35961702 [TBL] [Abstract][Full Text] [Related]
72. Integrative analyses of bulk and single-cell transcriptomics reveals the infiltration and crosstalk of cancer-associated fibroblasts as a novel predictor for prognosis and microenvironment remodeling in intrahepatic cholangiocarcinoma. Zhong YJ; Luo XM; Liu F; He ZQ; Yang SQ; Ma WJ; Wang JK; Dai YS; Zou RQ; Hu YF; Lv TR; Li FY; Hu HJ J Transl Med; 2024 May; 22(1):422. PubMed ID: 38702814 [TBL] [Abstract][Full Text] [Related]
73. Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma. Zheng T; Hong X; Wang J; Pei T; Liang Y; Yin D; Song R; Song X; Lu Z; Qi S; Liu J; Sun B; Xie C; Pan S; Li Y; Luo X; Li S; Fang X; Bhatta N; Jiang H; Liu L Hepatology; 2014 Mar; 59(3):935-46. PubMed ID: 24037855 [TBL] [Abstract][Full Text] [Related]
75. SOX2 knockdown slows cholangiocarcinoma progression through inhibition of transcriptional activation of lncRNA PVT1. Yu A; Zhao L; Kang Q; Li J; Chen K; Fu H Biochem J; 2020 Sep; 477(18):3527-3540. PubMed ID: 32812642 [TBL] [Abstract][Full Text] [Related]
76. Upregulated microRNA-194 impairs stemness of cholangiocarcinoma cells through the Rho pathway via inhibition of ECT2. Gao J; Dai C; Yu X; Yin XB; Zhou F J Cell Biochem; 2020 Oct; 121(10):4239-4250. PubMed ID: 31960990 [TBL] [Abstract][Full Text] [Related]
77. Downregulation of DAPK1 promotes the stemness of cancer stem cells and EMT process by activating ZEB1 in colorectal cancer. Yuan W; Ji J; Shu Y; Chen J; Liu S; Wu L; Zhou Z; Liu Z; Tang Q; Zhang X; Shu X J Mol Med (Berl); 2019 Jan; 97(1):89-102. PubMed ID: 30460377 [TBL] [Abstract][Full Text] [Related]
78. The zinc finger E-box-binding homeobox 1 ( Yan L; Li Y; Shi Z; Lu X; Ma J; Hu B; Jiao J; Wang H J Biol Chem; 2017 Aug; 292(31):12959-12970. PubMed ID: 28500132 [TBL] [Abstract][Full Text] [Related]
79. ZEB1 modulates endometrial receptivity through epithelial-mesenchymal transition in endometrial epithelial cells in vitro. Ran J; Yang HH; Huang HP; Huang HL; Xu Z; Zhang W; Wang ZX Biochem Biophys Res Commun; 2020 May; 525(3):699-705. PubMed ID: 32139122 [TBL] [Abstract][Full Text] [Related]
80. Epithelial-mesenchymal transition induced by transforming growth factor-{beta}1/Snail activation aggravates invasive growth of cholangiocarcinoma. Sato Y; Harada K; Itatsu K; Ikeda H; Kakuda Y; Shimomura S; Shan Ren X; Yoneda N; Sasaki M; Nakanuma Y Am J Pathol; 2010 Jul; 177(1):141-52. PubMed ID: 20489148 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]